Fuwen Yuan

7PUBLICATIONS
31CO-AUTHORS
Innate immunityMolecular targetsToxicology (incl. clinical toxicology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 01, 2026
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1.

|Aug 19, 2025
Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.

Junyan Xu, Dajun Gao, Changjie Ren

|Jun 19, 2025
Ezetimibe Engineered L14-8 Suppresses Advanced Prostate Cancer by Activating PLK1/TP53-SAT1-Induced Ferroptosis.

Yu Zhang, Xiao-Wen Song, Na Zhang

Pageof 2